Amneal Lines Up Launches As It Builds Out Biosimilars Business

Generics Sales Remain Flat In Q3, But Alymsys Bevacizumab Biosimilar Makes Solid Start

 
• By David Wallace
  
Dominoes lined up
Amneal is lining up multiple imminent biosimilar and generic launches • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business